Hivid (Zalcitabine, ddC)

Brand Name:	Hivid
Generic Name:	Zalcitabine, ddC
The manufacture and distribution of ddC (Hivid) was discontinued by the manufacturer as of February 15, 2006.
Drug Class:	NRTI

Zalcitabine (Hivid, ddC) (November 9, 2011)
To read PDF, click here.
From AIDS InfoNet
ddC (Hivid) (August 15, 2006)
From AIDS Treatment Data Network
Hivid (Zalcitabine) (November 2005)
[Archived Article]
To read PDF, click here.
From The Center for AIDS
Drug Interactions: Zalcitabine (August 2004)
[Archived Article]
From Project Inform
Patient Information About Hivid (Zalcitabine, ddC) (PDF) (September 2002)
From Roche

My Health Tracker

Assess Your Risk for HIV

U.S. ASO Finder

Find a Therapist

What Really Fuels the HIV/AIDS Epidemic in Black America?

Top 10 HIV/AIDS-Related Clinical Developments of 2011

Ten HIV/AIDS Stories that Defined 2011

The Culture War in the Black HIV/AIDS Movement Is Hurting Us All

Tennessee Senator: It's Virtually Impossible for Heterosexuals to Contract HIV From Sex: A Blog Entry by Kellee Terrell

More >>

The Body is a service of Remedy Health Media, LLC, 250 West 57th Street, New York, NY 10107. The Body and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.